4-Valent HPV Vaccine - Comprehensive Guard Against HPV-Related Ailments
ProcurenetShort description
4-Valent HPV Vaccine: A ground-breaking product offering broad protection against HPV Types 6, 11, 16, 18. Targets females aged 9 to 26 years. May prevent cervical, vulvar, and vaginal cancer, pre-cancerous lesions, and genital warts.
Highlights of the product include:
- Efficient Delivery: Administered intramuscularly in three 0.5-ml doses.
- Storage Requirements: Retains potency if kept between 2u00b0C to 8u00b0C and protected from light and freezing conditions.
- Convenient Packaging: Provided in cartons of one or ten single 0.5ml vials with volume of 15cm3/dose for a 10-vial carton; 75cm3/dose for a single-vial carton.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
4-Valent HPV Vaccine: Your Shield Against HPV-Related Health Complications
The 4-Valent Human Papillomavirus (HPV) Vaccine is a medical leap in the field of preventive healthcare, providing comprehensive protection against HPV-related cancers and diseases. This innovative recombinant vaccine is designed to offer immunity against diseases primarily caused by four prevalent HPV types 6, 11, 16, and 18. This includes cervical, vulvar, and vaginal cancers, as well as pre-cancerous or dysplastic lesions, genital warts, and persistent infections.
Key Features:
- Advanced Recombinant 4-Valent HPV Vaccine
- Primarily targets females aged 9 to 26 years
- Effective in preventing HPV-Related health complications
- Administered intramuscularly in three 0.5-ml doses
Storage and Packaging:
- Recommended storage temperature between 2u00b0C and 8u00b0C
- Avoid freezing
- Protection from light exposure is mandatory
- Packed in single-dose 0.5ml vials, available individually or in sets of ten
Specifications:
- Volume: 15cm3 per dose for ten-vial cartons, 75cm3 per dose for single-vial cartons
For an all-inclusive understanding of the vaccine specifications and the recommended usage, we advise visiting the 'Prequalified Vaccines' section on the World Health Organization (WHO) website. Our 4-valent HPV vaccine promises a proactive approach to health, offering robust protection against HPV-related complications with certified safety.
